AT
GILD icon

Avalon Trust’s Gilead Sciences GILD Stock Holding History

Avalon Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159K Sell
1,140
-18
-2% -$2.52K 0.01% 168
2025
Q4 		$142K Sell
1,158
-100
-8% -$12.2K 0.01% 172
2025
Q3 		$140K Buy
1,258
+118
+10% +$13.4K 0.01% 193
2025
Q2 		$126K Buy
+1,140
New +$121K 0.01% 175

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Avalon Trust's GILD Position: Q1 2026 in Review

Avalon Trust reduced its Gilead Sciences (GILD) stake by 1.6% in Q1 2026, selling an estimated $2.52K and leaving 1,140 shares worth $159K. The position accounts for 0.01% of the portfolio, ranked #168.

Avalon Trust first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Avalon Trust held 1,140 shares of Gilead Sciences worth $159K as of Q1 2026.
  • Avalon Trust sold 18 Gilead Sciences shares in Q1 2026, an estimated $2.52K.
  • Gilead Sciences made up 0.01% of Avalon Trust's portfolio in Q1 2026, its #168 holding.
  • Avalon Trust first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.